Overview Dividends

(MDLZ) Mondelez International - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6092071058

Biscuits, Chocolate, Candy, Cheese, Beverages

MDLZ EPS (Earnings per Share)

EPS Growth (3Y CAGR): -57.08%
EPS Trend (3Y Correlation): -50.4%

MDLZ Revenue

Revenue Growth (3Y CAGR): 5.46%
Revenue Trend (3Y Correlation): 57.0%

Description: MDLZ Mondelez International

Mondelez International (NASDAQ: MDLZ) is a global snack-food company that sells biscuits, crackers, snack bars, cakes, chocolates, gums, candies, cheese, grocery items and powdered beverages across North America, Latin America, Europe, Asia, the Middle East and Africa.

Its core brands include Oreo, Ritz, LU, CLIF Bar, Tate’s Bake Shop, Cadbury Dairy Milk, Milka and Toblerone, reaching consumers through supermarkets, club stores, convenience outlets, gasoline stations, drug stores, mass-merchandisers and e-retail platforms, with a mix of direct-store-delivery, warehouse distribution and third-party logistics.

In FY 2023 the company reported net revenue of $30.2 billion, with a 12 % organic growth rate in emerging markets driven by rising disposable income and urbanisation, while U.S. sales were flat due to inflation-squeezed consumer spending. The snack sector’s resilience to economic cycles and its shift toward “better-for-you” products remain key macro drivers.

Mondelez’s e-commerce share grew to roughly 8 % of total sales in 2023, reflecting accelerated digital adoption post-COVID-19, and the firm is investing in direct-to-consumer sites and data-analytics capabilities to capture higher-margin online demand.

For a deeper quantitative breakdown of MDLZ’s valuation metrics, the ValueRay platform offers a granular, data-driven view worth exploring.

MDLZ Stock Overview

Market Cap in USD	81,001m
Sub-Industry	Packaged Foods & Meats
IPO / Inception	2001-06-13

MDLZ Stock Ratings

Growth Rating	20.9%
Fundamental	58.3%
Dividend Rating	68.3%
Return 12m vs S&P 500	-21.1%
Analyst Rating	4.07 of 5

MDLZ Dividends

Dividend Yield 12m	3.04%
Yield on Cost 5y	3.80%
Annual Growth 5y	10.51%
Payout Consistency	96.7%
Payout Ratio	61.4%

MDLZ Growth Ratios

Growth Correlation 3m	-14.5%
Growth Correlation 12m	9.8%
Growth Correlation 5y	71%
CAGR 5y	4.97%
CAGR/Max DD 3y (Calmar Ratio)	0.20
CAGR/Mean DD 3y (Pain Ratio)	0.56
Sharpe Ratio 12m	-0.03
Alpha	-19.91
Beta	0.457
Volatility	21.58%
Current Volume	4036.8k
Average Volume 20d	6603.8k
Stop Loss	60.9 (-3%)
Signal	-0.30

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (3.64b TTM) > 0 and > 6% of Revenue (6% = 2.23b TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA -0.90pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -19.22% (prev -20.18%; Δ 0.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 4.16b > Net Income 3.64b (YES >=105%, WARN >=100%)

Net Debt (20.00b) to EBITDA (6.00b) ratio: 3.33 <= 3.0 (WARN <= 3.5)

Current Ratio 0.64 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.30b) change vs 12m ago -3.64% (target <= -2.0% for YES)

Gross Margin 32.49% (prev 40.34%; Δ -7.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 51.49% (prev 49.22%; Δ 2.28pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 8.59 (EBITDA TTM 6.00b / Interest Expense TTM 544.0m) >= 6 (WARN >= 3)

Altman Z'' 2.02

(A) -0.10 = (Total Current Assets 12.75b - Total Current Liabilities 19.88b) / Total Assets 71.02b

(B) 0.51 = Retained Earnings (Balance) 36.29b / Total Assets 71.02b

(D) 0.55 = Book Value of Equity 24.73b / Total Liabilities 44.77b

Total Rating: 2.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 58.32

1. Piotroski 5.50pt = 0.50

2. FCF Yield 2.83% = 1.42

3. FCF Margin 7.71% = 1.93

4. Debt/Equity 0.82 = 2.17

5. Debt/Ebitda 3.33 = -2.16

6. ROIC - WACC (= 1.26)% = 1.58

7. RoE 13.64% = 1.14

8. Rev. Trend 56.97% = 4.27

9. EPS Trend -50.44% = -2.52

What is the price of MDLZ shares?

As of October 21, 2025, the stock is trading at USD 62.81 with a total of 4,036,788 shares traded.
Over the past week, the price has changed by +2.68%, over one month by -0.29%, over three months by -8.79% and over the past year by -8.12%.

Is Mondelez International a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Mondelez International is currently (October 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 58.32 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MDLZ is around 60.98 USD . This means that MDLZ is currently overvalued and has a potential downside of -2.91%.

Is MDLZ a buy, sell or hold?

Mondelez International has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy MDLZ.

Strong Buy: 11
Buy: 8
Hold: 9
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the MDLZ price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	73.5	17%
Analysts Target Price	73.5	17%
ValueRay Target Price	66.6	6%

Last update: 2025-10-09 02:25

MDLZ Fundamental Data Overview

Market Cap USD = 81.00b (81.00b USD * 1.0 USD.USD)
P/E Trailing = 22.9304
P/E Forward = 18.622
P/S = 2.183
P/B = 3.052
P/EG = 4.7592
Beta = 0.457
Revenue TTM = 37.10b USD
EBIT TTM = 4.67b USD
EBITDA TTM = 6.00b USD
Long Term Debt = 18.12b USD (from longTermDebt, last quarter)
Short Term Debt = 2.77b USD (from shortTermDebt, last quarter)
Debt = 21.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.00b USD (from netDebt column, last quarter)
Enterprise Value = 101.00b USD (81.00b + Debt 21.50b - CCE 1.50b)
Interest Coverage Ratio = 8.59 (Ebit TTM 4.67b / Interest Expense TTM 544.0m)
FCF Yield = 2.83% (FCF TTM 2.86b / Enterprise Value 101.00b)
FCF Margin = 7.71% (FCF TTM 2.86b / Revenue TTM 37.10b)
Net Margin = 9.81% (Net Income TTM 3.64b / Revenue TTM 37.10b)
Gross Margin = 32.49% ((Revenue TTM 37.10b - Cost of Revenue TTM 25.05b) / Revenue TTM)
Gross Margin QoQ = 32.44% (prev 26.09%)
Tobins Q-Ratio = 1.42 (Enterprise Value 101.00b / Total Assets 71.02b)
Interest Expense / Debt = 0.70% (Interest Expense 151.0m / Debt 21.50b)
Taxrate = 26.32% (230.0m / 874.0m)
NOPAT = 3.44b (EBIT 4.67b * (1 - 26.32%))
Current Ratio = 0.64 (Total Current Assets 12.75b / Total Current Liabilities 19.88b)
Debt / Equity = 0.82 (Debt 21.50b / totalStockholderEquity, last quarter 26.19b)
Debt / EBITDA = 3.33 (Net Debt 20.00b / EBITDA 6.00b)
Debt / FCF = 6.99 (Net Debt 20.00b / FCF TTM 2.86b)
Total Stockholder Equity = 26.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.13% (Net Income 3.64b / Total Assets 71.02b)
RoE = 13.64% (Net Income TTM 3.64b / Total Stockholder Equity 26.69b)
RoCE = 10.43% (EBIT 4.67b / Capital Employed (Equity 26.69b + L.T.Debt 18.12b))
RoIC = 7.46% (NOPAT 3.44b / Invested Capital 46.19b)
WACC = 6.19% (E(81.00b)/V(102.51b) * Re(7.70%) + D(21.50b)/V(102.51b) * Rd(0.70%) * (1-Tc(0.26)))
Discount Rate = 7.70% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.41%
[DCF Debug] Terminal Value 77.88% ; FCFE base≈3.16b ; Y1≈3.07b ; Y5≈3.08b
Fair Price DCF = 42.38 (DCF Value 54.84b / Shares Outstanding 1.29b; 5y FCF grow -3.84% → 3.0% )
EPS Correlation: -50.44 | EPS CAGR: -57.08% | SUE: -4.0 | # QB: 0
Revenue Correlation: 56.97 | Revenue CAGR: 5.46% | SUE: 0.56 | # QB: 0

Additional Sources for MDLZ Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle